InvestorsHub Logo
Followers 104
Posts 2500
Boards Moderated 0
Alias Born 12/02/2016

Re: upanddown66 post# 38650

Tuesday, 05/16/2017 11:56:31 AM

Tuesday, May 16, 2017 11:56:31 AM

Post# of 96050
Did you read the news article?

The PR is about $TXTM and the respective Phytofare Type-II diabetes human clinical trial, also known as "Clinical Trial on Humans to determine the efficacy of Phytofare(R) for lowering HbA1C levels in II Diabetes patients".

$TXTM is the licensee and $PLPL is the supplier - the business relationship between the two stated companies is made very clear in the PR that I posted..imo